company CSBR - SteadyBase

steadybase-$ company CSBR

account_id none on file

legal_name Champions Oncology, Inc.

ticker CSBR

cik 771856

domain championsoncology.com

linkedin_company_url https://www.linkedin.com/company/champions-oncology-inc-/mycompany/

entry_point_account_id none on file

name Champions Oncology Inc.

exchange Nasdaq

sector Health Care

hq Baltimore, MD, United States

irhttps://www.championsoncology.com/investor-relations?hsLang=en

sector index/company/sector/health-care/

calls 1 filings 13 executives 12 family 0

why_nownone on file

calls

These operating expenses were partially offset by modest declines in R&D and G&A. We're encouraged that the business development investments are already contributing to pipeline expansion and will support growth in high margin data revenue moving forward, while at the same time remain focused on expense management and reduction in non-core areas of the business.

Jul 23, 2025 / receipt, needs a key / David Miller, CFO | earnings call 2025-07-23 | transcript 88058029-d6cd-462b-a4d6-9dcc21425bc6 | chars 7465-7829 | segment 7

filings

Based on that assessment, our management, including our Chief Executive Officer and our Chief Financial Officer, have concluded that our disclosure controls and procedures were effective as of July 31, 2026 at the reasonable assurance level in ensuring that information required to be disclosed in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time

filing / Sep 11, 2026 / receipt

• 1330 Piccard Drive Suite 025, Rockville, MD 20850, which consists of laboratory and office space where the Company conducts operations related to its primary service offerings.

filing / Sep 11, 2026 / receipt

• VIA LEONE XIII, 14, Milan, Italy, which consisted of laboratory and office space where the Company conducted operations related to its flow cytometry service offerings.

filing / Sep 11, 2026 / receipt

Robert Brainin Chief Executive Officer and Director (1)